Kawasaki Disease: Pathology, Risks, and Management

References

• Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi. 1967;16:178–222. Japanese.
   PubMedGoogle Scholar
• Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–276. doi:10.1542/peds.54.3.271
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am Coll Cardiol. 2016;67:1738–1749. doi:10.1016/j.jacc.2015.12.073
   PubMed Web of Science ®Google Scholar
• Makino N, Nakamura Y, Yashiro M, et al. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016. Pediatr Int. 2019;61:397–403. doi:10.1111/ped.13809
   PubMed Web of Science ®Google Scholar
• McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-Term management of Kawasaki disease: a Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135:e927–e999. doi:10.1161/CIR.0000000000000484
   PubMed Web of Science ®Google Scholar
• Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics. 1989;84:666–669. doi:10.1542/peds.84.4.666
   PubMed Web of Science ®Google Scholar
• Banday AZ, Bhattacharya D, Pandiarajan V, et al. Kawasaki disease in siblings in close temporal proximity to each other-what are the implications? Clin Rheumatol. 2021;40:849–855. doi:10.1007/s10067-020-05328-5
   PubMed Web of Science ®Google Scholar
• Mardi P, Esmaeili M, Iravani P, Abdar ME. Pourrostami K and Qorbani M. Characteristics of children with Kawasaki disease-like sin COVID-19 pandemic: a systematic review. Front Pediatr. 2021;9:625377. doi:10.3389/fped.2021.625377
   PubMed Web of Science ®Google Scholar
• Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395:1771–1778. doi:10.1016/S0140-6736(20)31103-X
   PubMed Web of Science ®Google Scholar
• Belhadjer Z, Meot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142:429–436. doi:10.1161/CIRCULATIONAHA.120.048360
   PubMed Web of Science ®Google Scholar
• Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. doi:10.1136/bmj.m2094
   PubMed Web of Science ®Google Scholar
• Ae R, Shibata Y, Kosami K, et al. Kawasaki disease and pediatric infectious diseases during the coronavirus disease 2019 pandemic. J Pediatr. 2021;239:50–58. doi:10.1016/j.jpeds.2021.07.053
   PubMed Web of Science ®Google Scholar
• Tsuda E, Hamaoka K, Suzuki H, et al. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J. 2014;167:249–258. doi:10.1016/j.ahj.2013.10.025
   PubMed Web of Science ®Google Scholar
• Miura M, Kobayashi T, Kaneko T, et al. Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr. 2018;172:e180030. doi:10.1001/jamapediatrics.2018.0030
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379:1613–1620. doi:10.1016/S0140-6736(11)61930-2
   PubMed Web of Science ®Google Scholar
• Tremoulet AH, Jain S, Jaggi P, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a Phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:1731–1738. doi:10.1016/S0140-6736(13)62298-9
   PubMed Web of Science ®Google Scholar
• Hamada H, Suzuki H, Onouchi Y, et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial. Lancet. 2019;393:1128–1137. doi:10.1016/S0140-6736(18)32003-8
   PubMed Web of Science ®Google Scholar
• Kanai T, Ishiwata T, Kobayashi T, et al. Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease: a retrospective study. Circulation. 2011;124:2822–2828. doi:10.1161/CIRCULATIONAHA.111.028423
   PubMed Web of Science ®Google Scholar
• Mori M, Imagawa T, Katakura S, et al. Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin. Mod Rheumatol. 2004;14:43–47. doi:10.3109/s10165-003-0264-3
   PubMedGoogle Scholar
• Harnden A, Takahashi M, Burgner D. Kawasaki disease. BMJ. 2009;338:b1514. doi:10.1136/bmj.b1514
   PubMed Web of Science ®Google Scholar
• Fukazawa R, Ogawa S. Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis? J Nippon Med Sch. 2009;76:124–133. doi:10.1272/jnms.76.124
   PubMedGoogle Scholar
• Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S. Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis. 2010;3:173–181. doi:10.3400/avd.sasvp01003
   PubMedGoogle Scholar
• Greco A, De Virgilio A, Rizzo MI, et al. Kawasaki disease: an evolving paradigm. Autoimmun Rev. 2015;14:703–709. doi:10.1016/j.autrev.2015.04.002
   PubMed Web of Science ®Google Scholar
• Takahashi K, Oharaseki T, Yokouchi Y. Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int J Rheum Dis. 2018;21:31–35. doi:10.1111/1756-185X.13207
   PubMed Web of Science ®Google Scholar
• Harada M, Yokouchi Y, Oharaseki T, et al. Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology. 2012;61:1156–1167. doi:10.1111/j.1365-2559.2012.04332.x
   PubMed Web of Science ®Google Scholar
• Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J. 1979;43:741–748. doi:10.1253/jcj.43.741
   PubMedGoogle Scholar
• Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 1980;30:681–694.
   PubMedGoogle Scholar
• Landing BH, Larson EJ. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol. 1987;1:218–229.
   PubMedGoogle Scholar
• Zhao QM, Chu C, Wu L, et al. Systemic artery aneurysms and Kawasaki disease. Pediatrics. 2019;1:144.
   Google Scholar
• Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379–1385. doi:10.1161/01.CIR.94.6.1379
   PubMed Web of Science ®Google Scholar
• Kato H, Inoue O, Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev. 1988;9:209–217. doi:10.1542/pir.9.7.209
   PubMedGoogle Scholar
• Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340:115–126. doi:10.1056/NEJM199901143400207
   PubMed Web of Science ®Google Scholar
• Gupta-Malhotra M, Gruber D, Abraham SS, et al. Atherosclerosis in survivors of Kawasaki disease. J Pediatr. 2009;155:572–577. doi:10.1016/j.jpeds.2009.04.054
   PubMed Web of Science ®Google Scholar
• Selamet Tierney ES, Newburger JW. Are patients with Kawasaki disease at risk for premature atherosclerosis? J Pediatr. 2007;151:225–228. doi:10.1016/j.jpeds.2007.05.011
   PubMed Web of Science ®Google Scholar
• Orenstein JM, Shulman ST, Fox LM, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One. 2012;7:e38998. doi:10.1371/journal.pone.0038998
   PubMed Web of Science ®Google Scholar
• Hirai T, Sasayama S, Kawasaki T. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989;80:78–86. doi:10.1161/01.CIR.80.1.78
   PubMed Web of Science ®Google Scholar
• Duprez DA, Cohn JN. Arterial stiffness as a risk factor for coronary atherosclerosis. Curr Atheroscler Rep. 2007;9:139–144. doi:10.1007/s11883-007-0010-y
   PubMedGoogle Scholar
• Yu X, Hirono KI, Ichida F, et al. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease. Pediatr Res. 2004;55:688–694. doi:10.1203/01.PDR.0000113464.93042.A4
   PubMed Web of Science ®Google Scholar
• Yahata T, Hamaoka K. Oxidative stress and Kawasaki disease: how is oxidative stress involved from the acute stage to the chronic stage? Rheumatology. 2017;1:6–13. doi:10.1093/rheumatology/kew044
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–1115. doi:10.1016/0140-6736(92)93147-F
   PubMed Web of Science ®Google Scholar
• Cheung YF, Woo OK. Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr. 2008;8:20. doi:10.1186/1471-2431-8-20
   PubMed Web of Science ®Google Scholar
• Zeng YY, Chen F, Zhang Y, Ji X. Are patients recovering from Kawasaki disease at increased risk for accelerated atherosclerosis? A meta-analysis. World J Pediatr. 2021;17:476–483. doi:10.1007/s12519-021-00452-x
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu MG, Xie LJ, Huang M, Shen J, Xiao TT. Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease. World J Pediatr. 2016;12:308–313. doi:10.1007/s12519-016-0023-0
   PubMed Web of Science ®Google Scholar
• Dietz SM, Tacke CE, Hutten BA, et al. Peripheral endothelial (Dys)function, arterial stiffness and carotid intima-media thickness in patients after Kawasaki Disease: a systematic review and meta-analyses. PLoS One. 2015;10:e0130913. doi:10.1371/journal.pone.0130913
   PubMed Web of Science ®Google Scholar
• Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996;94:2103–2106. doi:10.1161/01.CIR.94.9.2103
   PubMed Web of Science ®Google Scholar
• Huang SM, Weng KP, Chang JS, Lee WY, Huang SH, Hsieh KS. Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: a pilot study. Circ J. 2008;72:1583–1587. doi:10.1253/circj.CJ-08-0121
   PubMed Web of Science ®Google Scholar
• Deng YB, Xiang HJ, Chang Q, et al. Evaluation by high-resolution ultrasonography of endothelial function in brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Circ J. 2002;66:908–912. doi:10.1253/circj.66.908
   PubMed Web of Science ®Google Scholar
• Kadono T, Sugiyama H, Hoshiai M, et al. Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol. 2005;26:385–390. doi:10.1007/s00246-004-0755-9
   PubMed Web of Science ®Google Scholar
• Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol. 2005;26:782–786. doi:10.1007/s00246-005-0921-8
   PubMed Web of Science ®Google Scholar
• Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr. 2008;167:189–196. doi:10.1007/s00431-007-0452-9
   PubMed Web of Science ®Google Scholar
• Liu XQ, Huang GY, Liang XV, et al. Endothelial progenitor cells and arterial functions in the late convalescence period of Kawasaki disease. Acta Paediatr. 2009;98:1355–1359. doi:10.1111/j.1651-2227.2009.01334.x
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Iwashima S. Endothelial dysfunction in children within 5 years after onset of Kawasaki disease. J Pediatr. 2013;163:1117–1121. doi:10.1016/j.jpeds.2013.04.046
   PubMed Web of Science ®Google Scholar
• McCrindle BW, McIntyre S, Kim C, Lin T, Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr. 2007;151:244–248, 248.e1. doi:10.1016/j.jpeds.2007.03.056
   PubMed Web of Science ®Google Scholar
• Silva AA, Maeno Y, Hashmi A, et al. Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr. 2001;138:400–405. doi:10.1067/mpd.2001.111430
   PubMed Web of Science ®Google Scholar
• Borzutzky A, Gutierrez M, Talesnik E, et al. High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease. Clin Rheumatol. 2008;27:845–850. doi:10.1007/s10067-007-0808-6
   PubMed Web of Science ®Google Scholar
• Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J. 2003;146:168–174. doi:10.1016/S0002-8703(03)00094-2
   PubMed Web of Science ®Google Scholar
• Hamburg NM, Palmisano J, Larson MG, et al. Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension. 2011;57:390–396. doi:10.1161/HYPERTENSIONAHA.110.160812
   PubMed Web of Science ®Google Scholar
• Selamet Tierney ES, Gal D, Gauvreau K, et al. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013;62:1114–1121. doi:10.1016/j.jacc.2013.04.090
   PubMed Web of Science ®Google Scholar
• Tobayama H, Takahashi K, Fukunaga H, et al. Analysis of arterial function in adults with a history of Kawasaki disease. J Cardiol. 2013;61:330–335. doi:10.1016/j.jjcc.2012.12.007
   PubMed Web of Science ®Google Scholar
• Pinto FF, Laranjo S, Parames F. Long-term evaluation of endothelial function in Kawasaki disease patients. Cardiol Young. 2013;23:517–522. doi:10.1017/S1047951112001357
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605. doi:10.1093/eurheartj/ehl254
   PubMed Web of Science ®Google Scholar
• Bruno RM, Bianchini E, Faita F, Taddei S, Ghiadoni L. Intima media thickness, pulse wave velocity, and flow mediated dilation. Cardiovasc Ultrasound. 2014;12:34. doi:10.1186/1476-7120-12-34
   PubMed Web of Science ®Google Scholar
• Vaujois L, Dallaire F, Maurice RL, et al. The biophysical properties of the aorta are altered following Kawasaki disease. J Am Soc Echocardiogr. 2013;26:1388–1396. doi:10.1016/j.echo.2013.08.022
   PubMed Web of Science ®Google Scholar
• AlHuzaimi A, Al Mashham Y, Potts JE, De Souza AM, Sandor GG. Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease. J Am Soc Echocardiogr. 2013;26:1084–1089. doi:10.1016/j.echo.2013.05.015
   PubMed Web of Science ®Google Scholar
• Ooyanagi R, Fuse S, Tomita H, et al. Pulse wave velocity and ankle brachial index in patients with Kawasaki disease. Pediatr Int. 2004;46:398–402. doi:10.1111/j.1442-200x.2004.01929.x
   PubMed Web of Science ®Google Scholar
• Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol. 2004;43:120–124. doi:10.1016/j.jacc.2003.08.030
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yang SI, Kim KH, Kim JN, Kil HR. Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease. Korean J Pediatr. 2014;57:217–221. doi:10.3345/kjp.2014.57.5.217
   PubMedGoogle Scholar
• Cheung YF, Ho MH, Ip WK, et al. Modulating effects of mannose binding lectin genotype on arterial stiffness in children after Kawasaki disease. Pediatr Res. 2004;56:591–596. doi:10.1203/01.PDR.0000139406.22305.A4
   PubMed Web of Science ®Google Scholar
• Cheung YF, Wong SJ, Ho MH. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child. 2007;92:43–47. doi:10.1136/adc.2006.096628
   PubMed Web of Science ®Google Scholar
• Lee SJ, Ahn HM, You JH, et al. Carotid intima-media thickness and pulse wave velocity after recovery from Kawasaki disease. Korean Circ J. 2009;39:264–269. doi:10.4070/kcj.2009.39.7.264
   PubMedGoogle Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–1327. doi:10.1016/j.jacc.2009.10.061
   PubMed Web of Science ®Google Scholar
• Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13:101–107. doi:10.5551/jat.13.101
   PubMed Web of Science ®Google Scholar
• Branwell JC, Hill AV. Velocity of the Pulse wave in Man. Proc Roy Soc. 1922;B:298–306.
   Google Scholar
• Nakagawa R, Kuwata S, Kurishima C, et al. Arterial stiffness in patients after Kawasaki disease without coronary artery involvement: assessment by performing brachial ankle pulse wave velocity and cardio-ankle vascular index. J Cardiol. 2015;66:130–134. doi:10.1016/j.jjcc.2014.10.003
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–467. doi:10.1161/CIRCULATIONAHA.106.628875
   PubMed Web of Science ®Google Scholar
• Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055–1058. doi:10.1016/S0140-6736(84)91504-6
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341–347. doi:10.1056/NEJM198608073150601
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–1639. doi:10.1056/NEJM199106063242305
   PubMed Web of Science ®Google Scholar
• Oates-Whitehead RM, Baumer JH, Haines L, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2003;4:CD004000.
   Google Scholar
• Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics. 2000;105:E78. doi:10.1542/peds.105.6.e78
   PubMed Web of Science ®Google Scholar
• Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr. 2000;137:172–176. doi:10.1067/mpd.2000.104815
   PubMed Web of Science ®Google Scholar
• Durongpisitkul K, Soongswang J, Laohaprasitiporn D, et al. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol. 2003;24:145–148. doi:10.1007/s00246-002-0216-2
   PubMed Web of Science ®Google Scholar
• Wei M, Huang M, Chen S, et al. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease. Pediatr Cardiol. 2015;36:1166–1172. doi:10.1007/s00246-015-1138-0
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606–2612. doi:10.1161/CIRCULATIONAHA.105.592865
   PubMed Web of Science ®Google Scholar
• Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149:237–240. doi:10.1016/j.jpeds.2006.03.050
   PubMed Web of Science ®Google Scholar
• Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007;166:131–137. doi:10.1007/s00431-006-0223-z
   PubMed Web of Science ®Google Scholar
• Sleeper LA, Minich LL, McCrindle BM, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158:831–835e3. doi:10.1016/j.jpeds.2010.10.031
   PubMed Web of Science ®Google Scholar
• Fabi M, Andreozzi L, Corinaldesi E, et al. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort. Eur J Pediatr. 2019;178:315–322. doi:10.1007/s00431-018-3297-5
   PubMed Web of Science ®Google Scholar
• Yamada K, Fukumoto T, Shinkai A, Shirahata A, Meguro T. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Nihon Ketsueki Gakkai Zasshi. 1978;41:791–802.
   PubMedGoogle Scholar
• Schmidt-Lucke C, Fichtlscherer S, Rössig L, Kämper U, Dimmeler S. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis. 2010;211:249–254. doi:10.1016/j.atherosclerosis.2010.02.007
   PubMed Web of Science ®Google Scholar
• de Jongh S, Lilien MR, op’t Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002;40:2117–2121. doi:10.1016/S0735-1097(02)02593-7
   PubMed Web of Science ®Google Scholar
• Tsuda E, Kitamura S; Cooperative study group of J. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation. 2004;110:II61–1166. doi:10.1161/01.CIR.0000138194.61225.10
   PubMed Web of Science ®Google Scholar
• Masuda M; Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery. Thoracic and cardiovascular surgery in Japan during 2015: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 66;2018:581–615. doi:10.1007/s11748-018-0968-0
   PubMed Web of Science ®Google Scholar